MedTrace Logo

AMIE's Clinical Conversational Abilities in an Urgent Care Setting

NCT06911398 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-04-20

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility of a conversational artificial intelligence (AI) system to have a meaningful clinical conversation with a patient prior to an urgent care visit with their primary care physician. In this study, patients who are seeking an urgent care visit (that is, any type of medical visit with their primary care provider for a new complaint) will first have a conversation with an AI system. This interaction with the AI system will happen less than a week before their visit with their physician, and will be supervised by an independent physician who will interrupt in case there are any concerns about patient safety. After the interaction, a summary of the conversation will be sent to the patient's PCP, who will review prior to the in-person visit.

The researchers will investigate:

* Patient views on the AI system
* PCP views on the AI system
* Overall safety, as measured by the physician safety supervisor
* Quality of clinical conversations, measured by standardized rubrics
* Quality of diagnostic and management plans generated by the AI; these will not be shared with the patient or physician, but will be generated after the fact and compared with the actual diagnosis and management plan.

Conditions

  • Artificial Intelligence (AI)
  • Clinical Reasoning

Interventions

OTHER

Articulate Medical Intelligence Explorer (AMIE)

AMIE is an AI system for having clinical conversations with patients

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-02
Primary Completion
2026-01-05
Completion
2026-04-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06911398 on ClinicalTrials.gov